Actually, Block has probably been out of his short on NQ for quite some time since he is a "hit and run" type of short seller. Apple is most likely working for one of the hedge funds who are short NQ. Since he's probably paid by the reply, the best move is to nerve reply to his lies. I've had him on ignore for over a year and I noticed this morning that when I clicked on the MB, I had bunches of ignored posts from last night. Apple must have been assigned some overtime. Ignore is one of the best features on Yahoo.
Sandler may be right simply because the company got the raw data 19 weeks ago and compiling the data, in no way takes 4.7 months. the data is either less than stellar or Missling is playing the ego game by wanting to wait for a major conference "of his peers" to unveil it. He's sending a signal to the street that shareholders are not a priority in his mind.
I'm with you on the management situation. Murphy won't in any way cooperate with the analyst community and it has done definitive damage to the share price. I believe in the science and I'm holding far more shares than I should but if he is his secretive self on the CC, the share price goes to hell and I'll probably take a big loss and move on. His attitude that he's running a middle school science project simply doesn't cut it.
Without Wall Streets cooperation, the share price goes nowhere but down and about the only worse thing he could do is float another secondary. The institutions that he sold to at $4.25 are not his biggest supporters so let's hope that he uses some common sense.
It's easy to say have patience but when you are invested in a company that the CEO can't produce important results in 16 weeks after receiving the raw data, it's quite easy to see that the company and the CEO are the best friends of the shorts. If you are going to be a public company, your most important product is your share price.
You're absolutely right. If Murphy doesn't start acting the CEO of a public company, we're screwed for the next year
People may blame Missling simply because he's the CEO and can't seem to control his subcontractor. He's had the raw data since January and with no release of the compilation, he and the stock have become prime targets of the short selling hedge funds. The basics; ie the news from Australia are good but without the statistics, the market sees the path of least resistance is to short. The statement about a "major conference" being the venue to release the information is nothing but Missling's ego talking to impress his "peers". The problem is simply that his peers are not the ones investing in the company and the shareholders, who he should be trying to impress, are getting killed.
Another scientist who should not be CEO of a public company.
Missling, showing up at a shareholder meeting with absolutely nothing, is a sign that he's not the best man for the job. Biggest mistake was not taking advantage of the Australian news. After reviewing the "black out" rules, it's plain to see that there was absolutely nothing preventing the company from picking up on the Australian news and using it.
Whenever any of us writes to IR, we get the same canned reply telling us nothing and espousing "encouraging" platitudes. Missling should have enough sway over his subcontractors to get results in less that 16 weeks after submission. Big pharma partnerships are a wonderful hope but hope is not a proven investment strategy. I'm a believer in the science and have a six figure number of shares but the lack of support from the company is daunting and if he doesn't reveal something at the next meeting, it will be time to chalk this one up to a great idea and possibly great science but rotten implementation.
If the board hired a savvy CEO and made Missling chief scientific officer, the stock would probably go over 6 immediately.
meeting ended and now everyone sells. It's the egotistical CEO's in the small biotechs that screw the PPS up. After 16 weeks of having the raw data and not revealing results, he's proven to Wall Street that he simply can't deliver. The reason that companies like these are targets for short sellers is simply that they employ "hope" as an investing strategy. Missling made sure that his salary was far more than equitable and now he lets the shareholders swing in the wind. He didn't even attempt to get the Australian news replayed and, by the way, the blackout does not extend to independent news services in foreign countries. He's basically lost credibility with the institutional buyers and it ends up costing those of us who are long considerable amounts of money.
I certainly hope that there are some pointed questions put to Missling like:
1. Why has the raw data, available since early January, taken almost 17 weeks to be compiled into a salient release and why hasn't the company pressed the third party provider to do their job in a timely manner? The lame emails from IR are simply no longer acceptable.
2. Why hasn't the company done anything at all to get the Australian media releases picked up in the United States?
3.Why hasn't the company pressed the SEC for more information on the supposed "investigation" and asked for a clarification as to who and what is being investigated?
If all they do at the meeting is spout more "we're very exited" and associated BS, the shorts will have a field day.
You're not only right but the idiots cant even read a yahoo key statistics number. Yahoo gives the number as .33, obtainable by any idiot that can point and click. When these hacks get paid to bash a company, they'll grasp at straws for whatever might get them paid.
After reading the article, it's hard to believe that someone shorting AVXL can sleep at night. Then again, most of the shorts on this board don't really appear to be caring or conscientious people.
Email it to the IR department where ineptitude reigns. Maybe someone at Anavex just might discover that US coverage would benefit the shareholders.
The only solution is for Missling to release the results or, at the very least, give an update with the links to th Australian news. He's asleep at the switch as far as Wall Street is concerned